Navigation Links
Synthetic catalyst mimics nature's 'hydrogen economy'

CHAMPAIGN, Ill. By creating a model of the active site found in a naturally occurring enzyme, chemists at the University of Illinois have described a catalyst that acts like nature's most pervasive hydrogen processor.

The researchers describe their work in a paper accepted for publication in the Journal of the American Chemical Society, and posted on the journal's Web site.

Scientists have long been puzzled by nature's ability to use cheap and plentiful building blocks iron, nickel and sulfur to achieve the catalytic performance seen in rare and expensive metals. In particular, two enzymes iron-iron hydrogenase and nickel-iron hydrogenase function as hydrogen processors, much like platinum.

"Nature relies on a very elaborate architecture to support its own 'hydrogen economy,' " said Thomas B. Rauchfuss, a professor of chemistry and corresponding author of the paper. "We cracked that design by generating mock-ups of the catalytic site to include the substrate hydrogen atom."

The researchers' model of the nickel-iron complex is the first to include a bridging hydride ligand, an essential component of the catalyst.

"By better understanding the mechanism in the nickel-iron hydrogenase active site, we are learning how to develop new kinds of synthetic catalysts that may be useful in other applications," said graduate student Bryan E. Barton, lead author of the paper.

"The study of hydrogenases offers plenty of potential glamour such as the hydrogen economy, green energy and bio-fuel cells but the lasting breakthroughs result from manipulable mechanistic models like ours," said graduate student and co-author Matthew Whaley. "By building a model that contains a hydride ligand, we have proven that the behavior of these natural catalysts can be understood and optimized."


Contact: James E. Kloeppel
University of Illinois at Urbana-Champaign

Page: 1

Related biology news :

1. Synthetic chemical offers solution for crops facing drought
2. Using combinatorial libraries to engineer genetic circuits advances synthetic biology
3. Orientation of antenna protein in photosynthetic bacteria described
4. Synthetic biology can help extend anti-malaria drug effectiveness
5. Milestone achieved toward production of malaria treatment using synthetic biology and fermentation
6. Synthetic biology key in the 21st century
7. Synthetic biology: Is ethics a showstopper?
8. Synthetic virus supports a bat origin for SARS
9. UNC scientists teach enzyme to make synthetic heparin in more varieties
10. Biosynthetics production with detours
11. Synthetic Biology: Coming Up Fast!
Post Your Comments:
(Date:10/12/2015)... 9, 2015 Research and Markets ( ... new report "Biometrics: Market Shares, Strategies, and Forecasts, ... --> --> The study is ... market segment. Research represents a selection from the mountains ... market materials, with selections made by the most senior ...
(Date:10/8/2015)... Calif. , Oct. 8, 2015 ... of human interface solutions, announced today that it ... of fiscal 2016 on Thursday, October 22, 2015, ... host a corresponding conference call for analysts and ... during which management may discuss forward-looking information.    ...
(Date:10/6/2015)... , Oct. 6, 2015 Track Group, Inc. ... that it has signed a contract with the Virginia ... the full range of sentences under the Department,s oversight. ... the Americas. "This contract with the Virginia DOC will ... US and advances our position as a trusted leader ...
Breaking Biology News(10 mins):
(Date:10/13/2015)... SPRINGS, Florida , October 13, 2015 ... AVXLD), Juno Therapeutics, Inc. (NASDAQ: JUNO ), and ... ARRY ), Avanex Life Sciences Corp. (OTCQX: AVXLD), ... Pharmaceuticals, Inc. (NASDAQ: PGNX ) --> ... and the biotech industry can potentially lead to advancements ...
(Date:10/13/2015)... 13, 2015  According to Kalorama Information, the ... $102 billion by the end of 2015. Clinical ... industry, as it is estimated that approximately 80% ... tests. In addition to diagnosing patients, clinical lab ... progression, monitor drug treatment and conditions, and determine ...
(Date:10/13/2015)... ... ... Proove Biosciences, a commercial and research leader ... Medicine of the University of Southern California (USC) Pain Center to study ... Clinical Objectives Linking Genotypic and Phenotypic Association with Pain Outcomes) is one of ...
(Date:10/12/2015)... 2015  MiMedx Group, Inc. (NASDAQ: MDXG ), ... and patent-protected processes to develop and market advanced products ... Sports Medicine, Ophthalmic, and the Dental sectors of healthcare, ... filed against the Company has been dismissed by the ... and CEO, stated, "As we suspected, this case was ...
Breaking Biology Technology: